Introduction
Several genetic-based reporter proteins are capable of serving as markers for gene transfer to cells in vitro. These include ␤-galactosidase, 1 green fluorescent protein (GFP), 2 ,3 red-shifted GFP derivatives, 4 melanin, 5 luciferase, 6 herpes virus thymidine kinase (TK), 7-9 the human type 2 dopamine receptor (D 2 R), 10 and human type 2 somatostatin receptor (hSSTr2). 11, 12 In general, expressed reporter proteins are detected by either light-based or gamma-ray detection systems. Certain light-based methods rely on fluorescence, either intrinsic to the reporter itself (GFP), or via a specific fluorescent probe. Detection methods include fluorescent microscopy, 2 fluorescence-activated cell sorting (FACS), 3, 4 and fluorescence-based plate readers. 13 Light emission is also the basis for the detection of the luciferase reporter protein, with detection afforded by a photon counter or optical camera. 6 A distinct advantage of light-based approaches is their application in high throughput in vitro screening systems. 6 Light-based approaches for detecting in vitro gene transfer are well established, and their application in vivo has just begun. [14] [15] [16] [17] Thus far, radiotracers have demonstrated potential for detecting the in vivo expression of proteins following reporter gene transfer. Cellular expression of a reporter gene can lead to specific accumuCorrespondence: KR lation of an administered radiotracer, the presence of which can be measured by gamma-ray detection. This approach has been applied to measure the in vivo expression of three different reporter genes, namely hSSTr2, TK, and D 2 R. [7] [8] [9] [10] [11] [12] [18] [19] [20] [21] [22] [23] [24] [25] [26] These studies emphasized the capability for in vivo imaging of the expressed reporters, using planar gamma camera imaging, singlephoton emission computed tomography (SPECT), and positron emission tomography (PET). To date, a geneticbased reporter system and gamma-ray imaging modality have not been combined for in vitro screening and validation of gene transfer. Utilization of this approach would permit high capacity screening of gene transfer to cells growing in cell culture plates, in a manner that complements and predicts successful in vivo imaging.
The purpose of the current investigation was to develop a high capacity in vitro method for imaging the expression of the hSSTr2 reporter gene following gene transfer. This was accomplished with human cancer cells growing in multi-well cell culture plates, with gene transfer by an adenovirus (Ad) encoding the hSSTr2 gene. Following transfer of the hSSTr2 gene, the expressed hSSTr2 surface receptor had the capacity to internalize a 99m Tclabeled somatostatin analogue (P2045) that was added to the incubation media. Because the radioactivity was trapped within the cellular monolayer adherent to the plates, the free and surface-bound radioactivity could be washed away before imaging. The internally bound radioactivity was a measure of the level of hSSTr2 receptor expression, which was directly related to Admediated gene transfer. The radioactivity bound within cells in the monolayer was detected by imaging with an
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Anger gamma camera. This high-capacity imaging method was validated by independent measurements of lysed cells in a gamma counter.
To establish this novel approach for detection of in vitro gene transfer, studies were conducted that included gamma camera imaging of hSSTr2 gene transfer to cells growing in six-well and 96-well plates. For comparison, expression of GFP was measured by flow cytometry analyses, following identical treatment of the cells with Ad-GFP. Tc in an individual well by gamma camera imaging was 0.0121 ± 0.0002%. The response of the gamma camera was linear for increasing levels of 99m Tc in the 96-well plates. A plot of c.p.s. versus added 99m Tc radioactivity (Bq) yielded a straight line (c.p.s. = 0.000107(Bq)), with a R 2 = 0.999. The background count (well area) for the gamma camera imaging was 0.04 c.p.s. Assuming a minimum detection of three times the background, the theoretical minimal detectable count rate would be 0.12 c.p.s. or 1120 Bq.
Results

Radiolabeling
Validation of hSSTr2 gene transfer
Imaging six-well plates: Figure 1 presents representative images of three six-well plates with two levels of added Tc-P2045 (each in triplicate). Figure 1a is the image obtained during incubation with the 99m Tc-P2045, while Figure 1b is the internally bound radioactivity after 1 h incubation, followed by acid washing. Only Ad-hSSTr2-infected cells (without excess P2405) had internally bound 99m Tc-P2045 (Figure 1b , No. 1). The internal binding was specific, since it was blocked in Ad-hSSTr2-infected cells with excess unlabeled P2045 (Figure 1b ROI analysis was performed on the images presented in Figure 1 , together with images from 2 and 4 h incubations (not shown). An additional correction was applied since only 70% of added radioactivity was 99m Tc-P2045 (from TLC analyses), while the remainder was free pertechnetate (TcO 4− ). Free pertechnetate did not interfere with the assay, but was present since the initial radiolabeling protocol used only 50 g of SnCl 2 , although 100 g of SnCl 2 was later determined to be optimal. The 100 g level of SnCl 2 was used for all subsequent experiments (96-well plates), and Ͼ98% yields of 99m Tc-P2045 were obtained.
Results for the six-well plates are summarized in Figure 2 , and indicate that the amount of internally bound 99m Tc-P2045 increased with time of incubation. Internally bound 99m Tc-P2045 (5 nm) averaged 51 ± 3%, 72 ± 4% and 82 ± 5%, for 1, 2 and 4 h of incubation, respectively. The 1 nm concentration of 99m Tc-P2045 was not significantly different from the 5 nm concentration (P Ͻ 0.05). Excess P2045 blocked (Ͼ95%) the internal binding of 99m Tc-P2045 at all concentrations and incubation times. Since the level of 99m Tc-P2045 internally bound in uninfected cells was not significantly different from zero (P Ͻ 0.05), the data are not included in Figure 2 . ROI analyses presented in Figure 2 and independent gamma counter measurements of lysed cells were also not significantly different (P Ͻ 0.05). Additional replicate experiments of the 1 and 4 h incubations yielded results that were not significantly different (data not shown).
Imaging 96-well plates -comparing four cell lines: Two 96-well plates contained four cell lines that were infected with Ad-hSSTr2 at 0, 1, 10 or 100 p.f.u. per cell. After 48 h the plate assay protocol described in Materials and methods was conducted using 99m Tc-P2045 at two concentrations (each in triplicate). Images are presented in Figure 3 , and show the added radioactivity during incubation (Figure 3a and b) and internally bound radioactivity after a 3 h incubation, followed by acid washing (Figure 3c and d) . Only Ad-hSSTr2-infected cells (without excess unlabeled P2405) had internally bound 99m Tc-P2045 (Figure 3c and d, lanes 1-6) . The internal binding was specific, since it was blocked in Ad-hSSTr2-infected cells with excess unlabeled P2045 (Figure 3c and d, lanes [7] [8] [9] [10] [11] [12] . Uninfected cells were also negative (Figure 3c and d, '0' rows).
A-427 and MDA-MB-468 cells showed maximum internally bound 99m Tc-P2045 at 10 p.f.u. per cell, while BxPC-3 and SKOV3.ip1 cells were maximal at 100 p.f.u. per cell. Visual inspection and protein analyses showed loss of A-427 and MDA-MB-468 cells with the infection at 100 p.f.u. per cell. No cells were lost for the BxPC-3 and SKOV3.ip1 cells infected at 100 p.f.u. per cell. Quantitative analyses were conducted on the images presented in Figure 3 , for the cells infected at 10 p.f.u. per cell. The results are summarized in Table 1 , together with the gamma counter results of the lysed cells. There was no significant difference (P Ͻ 0.05) between the imaging and gamma counter measurements of internally bound radioactivity. In addition, the manual and automated ROI analyses were in agreement. The latter method was approximately 10 times faster (1 min versus 10 min per row).
Lysed cells counted in the gamma counter were also subjected to Lowry protein analyses, and thereby the % internally bound 99m Tc-P2045 per g of total protein (% dose/g) was calculated. These data for A-427 cells are presented in Figure 4a . Inspection of Figure 4a shows that A-427 cells infected with Ad-hSSTr2 at 1 p.f.u. per cell had significantly lower % dose/g, as compared with the infections at 10 and 100 p.f.u. per cell. However, A-427 cells infected with Ad-hSSTr2 at 10 and 100 p.f.u. per cell were not significantly different, indicating maximal hSSTr2 expression occurred with an infection of 10 p.f.u. per cell. There was a difference in % dose/g for the two Tc-P2045. The 7 nm concentration had a significantly greater (P Ͻ 0.05) % dose/g, as compared with the 36 nm concentration. This was true for all levels of Ad-hSSTr2 infection. Data presented in Figure 4a also demonstrate the specificity of the technique for A-427 cells, and are representative for all tested cell lines. Uninfected cells, or cells incubated with excess unlabeled P2045, showed very low internally bound radioactivity (Ͻ0.02% dose/g). This indicated the internally bound radioactivity was dependent on surface expression and availability of hSSTr2 protein. Under the same conditions but on a separate plate, A-427 and SKOV3.ip1 cells infected with an Ad vector encoding thymidine kinase (Ad-TK, 10 and 100 p.f.u. per cell, respectively) also showed very low internally bound radioactivity (Ͻ0.01% dose/g). This result indicated that Ad infection would not increase hSSTr2 expression nonspecifically.
Data for SKOV3.ip1 cells are presented in Figure 4b . In contrast to A-427 cells, the % dose/g significantly increased (P Ͻ 0.05) in SKOV3.ip1 cells infected at 1, 10 and 100 p.f.u. per cell. The SKOV3.ip1 cells were more difficult to infect with Ad-hSSTr2, as compared with A-427 cells. Maximal % dose/g for SKOV3.ip1 occurred with an Ad-hSSTr2 infection of 100 p.f.u. per cell. With respect to the two levels of 99m Tc-P2045 and % dose/g, the SKOV3.ip1 cells showed the same trend as noted for the A-427 cells. Internally bound 99m Tc-P2045 was lower with the 36 nm concentration, as compared with the 7 nm concentration. The same difference as a function of 99m Tc-P2045 concentration was noted for the BxPC-3 and MDA-MB-468 cell lines as well (data not shown).
Imaging 96-well plates -dilution of Ad-hSSTr2-positive A427 cells: Triplicate wells in 96-well plates contained 100%, 80%, 60%, 40%, 20%, 10%, 5%, 1% and 0% AdhSSTr2-positive A-427 cells mixed with uninfected, hSSTr2-negative A-427 cells. The plate assay protocol was conducted using 99m Tc-P2045 (36 nm), the plate was imaged, and cells removed for counting in the gamma counter. Imaging analyses results were linearly correlated with gamma counter results (R 2 = 0.99); the line was described by the equation y = 0.98x + 0.0024 as shown in Figure 5 . These data indicated the accuracy of the imaging method, as validated by gamma counter analyses. In addition, the % dose internally bound in the wells as determined by imaging, was linearly correlated to % cells positive for hSSTr2 (R Figure 6a . The % dose internally bound per g of total protein was lowest (0.174%) for the highest concentration of 99m Tc-P2045 (56.8 nm). As the 99m Tc-P2045 concentration decreased to 2.84 nm, the % dose internally bound increased linearly. Subsequent dilutions below 2.84 nm did not significantly change the internally bound radioactivity, which remained constant at 0.4% dose per g of total protein.
The same data are plotted in Figure 6b , with the % dose internally bound converted to P2045 molecules internally bound per A-427 cell. As the data presented in Figure 6b show, the number of internally bound P2045 molecules was approaching a maximum (3 500 000 per cell) for the 56.8 nm 99m Tc-P2045 concentration.
Flow cytometry analyses
This experiment was conducted to independently verify the susceptibility of the four cell lines to Ad infection. Ad-GFP was utilized in the place of Ad-hSSTr2, but the same levels of infection were used as described previously (Imaging 96-well plates). The plate assay protocol was not conducted, since cells infected with Ad-GFP were analyzed by flow cytometry techniques. A-427 cells were 1%, 74%, 99% and 99% GFP positive, for Ad-GFP infections at 0, 1, 10 and 100 p.f.u. per cell, respectively. MDA-MB-468 cells were 1%, 48%, 96% and 99% GFP positive for the same Ad-GFP infection levels. The flow cytometry results showed a different trend for the other Gene Therapy cell lines. SKOV3.ip1 cells were 1%, 8%, 49% and 90% GFP positive, for Ad-GFP infections at 0, 1, 10 and 100 p.f.u. per cell, respectively, while BxPC-3 cells were 1%, 4%, 28% and 78% GFP positive, for the same Ad-GFP infection levels. Thus, for BxPC-3 and SKOV3.ip1 cells, the % positive cells increased when the Ad-GFP infection level changed from 10 to 100 p.f.u. per cell. In contrast, A-427 and MDA-MB-468 cells showed no difference in % positive cells for Ad-GFP infection levels of 10 and 100 p.f.u. per cell.
For Tc-P2045 and % hSSTr2-positive A-427 cells in the wells (range 1-100% positive). A further indication of the sensitivity was the fact that plate imaging detected only 1020 Bq of internalized activity in the wells of the 96-well plate, in close agreement with the predicted detection limit of 1120 Bq based on three times the background count rate.
For imaging the expression of hSSTr2 with 99m Tc-P2045, it was possible to image 96-well plates accurately. The Technicare 420/550 gamma camera used for this purpose was equipped with a high-resolution collimator, and four plates could be imaged simultaneously. A total of eight plates could be imaged each hour, for a total of approximately 768 samples per hour. This demonstrated the high capacity of the imaging system. This capacity is obviously lower than light-based in vitro screening systems based on luciferase or ␤-galactosidase, where plates with 384-, 864-or 1536-well configurations can be assayed. On the other hand, future plate imaging may be possible with a higher well capacity (eg 384), since new CdZnTe pixel array detectors have been reported with a spatial resolution of 0.38 mm or better. 27 A primary advantage of imaging the plates with a gamma camera is the ease in translating the approach for preclinical evaluations in animal models and humans, where the same radioisotope and imaging instrumentation could be Gene Therapy
Figure 6 Effect of 99m
Tc-P2045 concentration on Ad-hSSTr2-dependent internalization, expressed as (a) % dose internally bound per g total protein, or (b) P2045 molecules internally bound per A-427 cell. Data are expressed as means (± s.d.).
applied. A similar situation is not possible for the lightbased in vitro screening.
The gamma camera used in this study is approximately 20 years old and has conventional spatial resolution. Therefore, the imaging technique could be widely applied in most institutions. In the absence of a gamma camera, other detection methods are possible. As shown in this study, the cells can be removed from the plates and counted in a gamma counter. Alternatively, 96-well plates are available in configurations where individual wells can be manually separated and counted. Another option is to use a phosphor imager. This equipment will work with cell culture plates, provided a collimator is used. A thin film of lead immediately adjacent to the phosphor screen also improves efficiency of 99m Tc detection.
The technology reported here can be readily applied in the gene therapy field. For example, new gene therapy vectors with modified tropism can be tested. In the case of Ad vectors, the loop structure of the Ad knob can be modified to target the vector more specificity to defined cell types. 28 Using this technology, a genetically modified vector could be rapidly screened against numerous cell types and incubation conditions to determine relative transduction efficiency. Preliminary studies demonstrate the feasibility of this approach. 29 Another application of this technology will be inclusion of the hSSTr2 reporter gene in vectors containing other therapeutic genes as a means to detect therapeutic gene transfer. This approach is feasible since it is possible to construct biscistronic vectors. 1, 30, 31 Inclusion of a reporter gene that produces a protein that can be imaged with a radiolabeled substrate would be advantageous to measure gene transfer by quantitative noninvasive imaging, both in vitro and in vivo. As previously mentioned, one utility of the reporter proteins and radiolabeled substrates reported here is the relatively straight-forward adaptation of the method to animal models and human imaging studies for pre-clinical and clinical trials of new gene transfer therapies.
Plate imaging can also be applied in other ways. The reporter genes themselves may be modified to enhance their effectiveness for imaging. For example, modified ligands targeting the hSSTr2 receptor could be rapidly screened, or modifications to the hSSTr2 receptor could be tested to study the biology of the internalization process. A further adaptation would be to place the hSSTr2 gene under control of different promoter elements. The ability of the promoter elements to drive reporter and gene expression could thereby be evaluated, especially under varied conditions. Certain promoters may be active only in a specific cell type, hence the imaging system would allow many cell types to be rapidly tested and compared. Finally, plate imaging with a gamma camera could be used in combination with other existing protocols and equipment, including absorbance and fluorescence plate readers.
A high capacity screening system, based on gamma camera imaging, was validated for imaging the expression of hSSTr2 gene product following Admediated gene transfer to human cancer cells growing as monolayers in cell culture plates. This system will be useful for evaluating tropism-modified gene therapy vectors under various conditions.
Materials and methods
Human cell lines and Ad vectors
The human A-427 (non-small cell lung cancer), MDA-MB-468 (breast cancer), BxPC-3 (pancreatic cancer), and 293 (transformed primary embryonal kidney) cells were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). SKOV3.ip1 (human ovarian cancer) cells were obtained from Janet Price (Baylor University, Houston, TX, USA). Cells were grown in Eagle's minimum essential medium containing nonessential amino acids and 1 mm sodium pyruvate supplemented with 10% fetal bovine serum, as recommended by the ATCC. The cells were cultured at 37°C in a humidified atmosphere with 5% CO 2 . The replication-incompetent Ad (serotype 5) encoding hSSTr2 cDNA (type A) under the control of the CMV promoter element (Ad-hSSTr2) was produced and purified as previously described. 32 The replication-incompetent Ad (serotype 5) encoding GFP under control of the CMV promoter element (Ad-GFP) was obtained from Corey Goldman (Cleveland Clinic, Cleveland, OH, USA). The recombinant Ads were plaque purified, validated by PCR, and titered within 293 cells using plaque assay techniques for direct determination of viral plaque forming units (p.f.u.).
Radiolabeling
Chemicals were from Fisher (Pittsburgh, PA, USA) unless otherwise noted. P2045, a proprietary peptide (1450 Da) of Diatide (Londonderry, NH, USA), is chemically related to P829 (NeoTect), an FDA-approved, somatostatinreceptor imaging agent for solitary pulmonary nodules. [33] [34] [35] [36] P2045 has the additional property of rapid kidney clearance and excretion, and 188 Re-P2045 showed therapeutic efficacy in a mouse tumor model. 37 A kit containing 0.1 mg EDTA, 10 mg glucoheptonate, and 50 g of SnCl 2 dihydrate was injected with 1 ml of saline containing 1.9 GBq of 99m TcO 4− (Central Pharmacy, Birmingham, AL, USA). This was followed by addition of 50 g of P2045 in 0.2 ml saline (0.9%) and 50 g of SnCl 2 dihydrate in absolute ethanol. The mixture was boiled for 10 min. The radiolabeled P2045 peptide was subjected to instant thin layer chromatography (ITLC) analyses. The ITLC silica gel strips (Gelman Sciences, Ann Arbor, MI, USA) were spotted with the radiolabeled P2045 peptide at one end, and eluted with either saturated saline, methyl ethyl ketone, or a 50:50 mixture of methanol and ammonium acetate (1 m) as the mobile phase. The 99m Tc-P2045 migrated only with the mixture of methanol and ammonium acetate.
Efficiency and linearity
Absolute efficiency for detecting the 140 keV gamma ray with the gamma camera was calculated using the standard equation: efficiency = c.p.s./(d.p.s. × branching ratio). The 99m Tc was pipetted in the wells (0.1 ml volume) of the 96-well plate, and the plate was positioned in direct contact with the gap collimator. This geometry was identical to all 96-well plate imaging studies. The branching ratio for 99m Tc is 0.8909, which implies
Gene Therapy that 89.09% of the decays result in a 140 keV gamma ray emission. For the linearity test, 12 serial dilutions of 99m Tc encompassing an approximate three log range (maximum = 0.4 MBq) were imaged in a 96-well plate, and compared with equivalent aliquots counted in the gamma counter.
Plate assay protocol
Cells at approximately 80% confluency in 75-cm 2 flasks were infected with Ad-hSSTr2 at the specified p.f.u. per cell. The Ad vector was diluted in EMEM containing 2% heat inactivated fetal bovine serum and 1 mm l-arginine. Infection was for 2 h at 37°C with gentle rocking, and was followed by changing to normal growth media. After 24 h the cells were trypsinized, counted, and seeded in the appropriate cell culture plates. The concentration of added cells was adjusted to ensure 85-95% confluency after 24 h. At that time the cells were washed twice with Hank's balanced salt solution (HBSS). After washing, incubation buffer (DMEM, with 30 mm Hepes, 2 mm lglutamine, 1 mm Na pyruvate, 1% bovine serum albumin; pH 7.4) was added to the wells, either alone or containing the appropriate amount of blocking compound, unlabeled P2045. Individual total well volumes for this assay were 0.1 and 1.2 ml, for the 96-well and six-well plates, respectively. In this initial step, 50% of the total volume was added to each well. The remaining 50% was added after 5 min, and contained 99m Tc-P2045 at the indicated concentrations. All experiments were conducted in triplicate, with planar images collected after addition of the radiolabeled tracer. The cells were incubated for 1-4 h at 37°C in a humidified atmosphere with 5% CO 2 . At the appropriate time, the cells were washed twice with ice-cold HBSS, followed by a third wash with HBSS containing 20 mm Na acetate (pH 4.0, 10 min, 37°C) to remove surface-bound radioactivity. Following the acid wash, a volume of 1 n NaOH equivalent to the total incubation volume was added to each well. Plates were imaged, and the lysed cells were harvested to measure the amount of internally bound radioactivity and protein content by Lowry assay. 38 Data are presented as % internally bound, relative to total radioactivity added. Certain data were also normalized to protein content in the wells, and reported as % of internally bound activity per g of total protein. Protein content and cell numbers were measured on matched samples. This was done two times in triplicate. The cells were detached using 0.05% trypsin with 0.53 mm EDTA and counted manually with a hemocytometer. 
Validation of hSSTr2 gene transfer
Flow cytometry analyses
Ad-mediated gene transfer of GFP (using Ad-GFP) was evaluated in the four cancer cell lines by flow cytometry analyses. A-427, SKOV3.ip1, MDA-MB-468 and BxPC-3 cancer cells were grown in 75-cm 2 flasks and infected as described in the 'Plate Assay Protocol'. Expression of GFP resulting from Ad-GFP infection (0, 1, 10 or 100 p.f.u. per cell) was evaluated 48 h after infection by flow cytometry. Viable cells (500 000) were analyzed by fluorescence-activated cell sorting (FACS) at 10 000 events per sample using a FACScan instrument (Becton Dickinson, Mountain View, CA, USA) in the University of Alabama at Birmingham Immunopathology Core Facility. Flow cytometry results are reported as the % gated cells and total fluorescent signal. The gate was set using uninfected cells so that the % gated cells was 1%. A cell with fluorescent intensity higher than the gate value was reported as positive. Total fluorescent signal was calculated as the fraction of gated cells multiplied by the mean fluorescence of gated cells.
Summary of replication of experiments
All tests were done in triplicate and included two negative controls. The negative controls were uninfected cells, and Ad-infected cells with blocking reagents to test specificity. Gene transfer of hSSTr2 by itself was validated in six-well plates (three times) and 96-well plates (three times). The same four cells lines were tested by independent flow cytometry analyses following infection with Ad-GFP (once). An additional control experiment used A-427 and SKOV3.ip1 cells infected with Ad-TK.
Imaging and ROI analyses
Plates were imaged on the face of the collimators using a 512 × 512 matrix size. Imaging studies with 99m Tc used an Anger 420/550 Mobile Radioisotope Gamma Camera (Technicare, Solon, OH, USA) equipped with a low energy, parallel hole collimator (Model 14S22022). Intrinsic resolution of the 420/550 detector was 3.0 mm FWHM. Cell culture plates containing cell monolayers were imaged initially after addition of the radiotracer, and after appropriate incubation and washing. Planar imaging techniques were applied, with at least 50 000 total counts per image collected. Image acquisition time ranged from 5 to 40 min, with the longer time required for imaging the plates after washing.
Images were processed with a modified version of NIH Image (NucMed †Image, Mark D Wittry, St Louis University, St Louis, MO, USA) using two methods. In the first method, standard manual ROI analyses were conducted. ROI were drawn around the area representing the individual wells of the cell culture plates. The same ROI was used for the initial and final image analyses. Background regions at each imaging time were drawn outside the plate region. Mean counts per pixel was recorded for all regions. The average counts per pixel for the background region was subtracted from average counts per pixel in the well ROI. The fraction of internally bound activity for each well was calculated as the ratio between the final (after acid wash) decay and background corrected counts per pixel, divided by the initial, background corrected counts per pixel in the same well. The second method (for 96-well plates) used an automated ROI analyses. This method used the plot profile component of the software, whereby a rectangle (14 pixels wide by 180 pixels long) was drawn around the entire row of the cell culture plate image (12 wells) as illustrated in Figure 3 (A-427 cells, 10 p.f.u. per cell). The software automatically calculated the average counts per pixel (14-pixel width) along the entire 180-pixel length, and the data were exported to a spreadsheet for automated analyses. This consisted of an automated summing of the slices that represented the area of each individual well.
Other measurements
Radiotracer stock solutions were assayed using an Atomlab 100 dose calibrator (Biodex Medical Systems, Shirley, NY, USA). Lysed cell solutions were counted in a Minaxi Auto-Gamma 5000 series gamma counter (Packard, Downers Grove, IL, USA). Standards for 100% yield determination were prepared at the time the radiotracers were added to the wells of the cell culture dishes, and were counted along with the samples in the gamma counter. Statistical comparisons utilized analysis of variance protocols in the Statistical Analysis System. 39 
